{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:26:43Z","timestamp":1793896003803,"version":"4.8.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["GZC20252374"],"award-info":[{"award-number":["GZC20252374"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M760568"],"award-info":[{"award-number":["2024M760568"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["753748"],"award-info":[{"award-number":["753748"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574593"],"award-info":[{"award-number":["82574593"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074277"],"award-info":[{"award-number":["82074277"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374296"],"award-info":[{"award-number":["82374296"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jconrel.2026.115054","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T16:10:25Z","timestamp":1779811825000},"page":"115054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Synergistic remodeling of psoriatic immune niche via ginsenoside CK\/tofacitinib co-loaded dermal targeting transfersomes"],"prefix":"10.1016","volume":"396","author":[{"given":"Ru","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meichen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anni","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingxi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10281","key":"10.1016\/j.jconrel.2026.115054_bb0005","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2026.115054_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122991","article-title":"Advances in psoriasis research: from pathogenesis to therapeutics","volume":"355","author":"Sugumaran","year":"2024","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115054_bb0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-025-00630-5","article-title":"Psoriasis","volume":"11","author":"Armstrong","year":"2025","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.jconrel.2026.115054_bb0020","doi-asserted-by":"crossref","first-page":"1518681","DOI":"10.3389\/fpubh.2025.1518681","article-title":"Dynamic trend analysis of global psoriasis burden from 1990 to 2021: a study of gender, age, and regional differences based on GBD 2021 data","volume":"13","author":"Xiong","year":"2025","journal-title":"Front. Public Health"},{"key":"10.1016\/j.jconrel.2026.115054_bb0025","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"Bmj"},{"issue":"8","key":"10.1016\/j.jconrel.2026.115054_bb0030","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41573-023-00735-0","article-title":"Disease modification in inflammatory skin disorders: opportunities and challenges","volume":"22","author":"Bieber","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"Pt 1","key":"10.1016\/j.jconrel.2026.115054_bb0035","article-title":"Current therapeutic overview and future perspectives regarding the treatment of psoriasis","volume":"143","author":"Ferrara","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"14","key":"10.1016\/j.jconrel.2026.115054_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411662","article-title":"Inflammatory cytokines in psoriatic arthritis: understanding pathogenesis and implications for treatment","volume":"24","author":"Lee","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115054_bb0045","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jaci.2024.05.008","article-title":"Inflammatory memory in psoriasis: from remission to recurrence","volume":"154","author":"Francis","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115054_bb0050","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/ard-2024-225534","article-title":"Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis","volume":"83","author":"Kerschbaumer","year":"2024","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115054_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2024.03.008","article-title":"Full guidelines-from the Medical Board of the National Psoriasis Foundation: perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis","volume":"91","author":"James","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115054_bb0060","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/ard-2024-225531","article-title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update","volume":"83","author":"Gossec","year":"2024","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115054_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16020239","article-title":"New and emerging oral\/topical small-molecule treatments for psoriasis","volume":"16","author":"Carmona-Rocha","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115054_bb0070","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jconrel.2022.09.025","article-title":"Overcoming skin barriers through advanced transdermal drug delivery approaches","volume":"351","author":"Phatale","year":"2022","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115054_bb0075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4155\/tde-2020-0122","article-title":"Liposomes and transferosomes: a breakthrough in topical and transdermal delivery","volume":"12","author":"Sapkota","year":"2021","journal-title":"Ther. Deliv."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115054_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/nano11102557","article-title":"Ultraflexible liposome nanocargo as a dermal and transdermal drug delivery system","volume":"11","author":"Sudhakar","year":"2021","journal-title":"Nanomaterials (Basel)"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115054_bb0085","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2025.2464190","article-title":"Ginsenoside compound K-based multifunctional liposomes for the treatment of rheumatoid arthritis","volume":"32","author":"Zhang","year":"2025","journal-title":"Drug Deliv."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115054_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ph18040594","article-title":"Enhanced topical delivery of methotrexate via transferosome-loaded microneedle array patch: formulation, optimization, and in vitro-in vivo assessment","volume":"18","author":"Shinde","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jconrel.2026.115054_bb0095","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.omtn.2020.04.003","article-title":"Skin delivery of siRNA using sponge spicules in combination with cationic flexible liposomes","volume":"20","author":"Liang","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2026.115054_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105498","article-title":"Ginsenoside compound K- a potential drug for rheumatoid arthritis","volume":"166","author":"Tang","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115054_bb0105","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jgr.2018.04.004","article-title":"Ameliorative effects of ginseng and ginsenosides on rheumatic diseases","volume":"43","author":"Yi","year":"2019","journal-title":"J. Ginseng Res."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115054_bb0110","article-title":"Fermented and aged ginseng sprouts (panax ginseng) and their main component, compound K, alleviate asthma parameters in a mouse model of allergic asthma through suppression of inflammation, apoptosis, ER stress, and ferroptosis","volume":"11","author":"Ryu","year":"2022","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115054_bb0115","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jgr.2021.12.008","article-title":"Compound K ameliorates airway inflammation and mucus secretion through the regulation of PKC signaling in\u00a0vitro and in\u00a0vivo","volume":"46","author":"Lee","year":"2022","journal-title":"J. Ginseng Res."},{"key":"10.1016\/j.jconrel.2026.115054_bb0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ijbiomac.2022.05.177","article-title":"Structural characterization and anti-inflammatory properties of green synthesized chitosan\/compound K\u2011gold nanoparticles","volume":"213","author":"Mi","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2026.115054_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121700","article-title":"Compound K - an immunomodulator of macrophages in inflammation","volume":"323","author":"Choi","year":"2023","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115054_bb0130","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41577-021-00603-1","article-title":"Immune-mediated inflammatory disease therapeutics: past, present and future","volume":"21","author":"Mcinnes","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115054_bb0135","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.fct.2011.03.021","article-title":"Inhibition of JAK1\/STAT3 signaling mediates compound K-induced apoptosis in human multiple myeloma U266 cells","volume":"49","author":"Park","year":"2011","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.jconrel.2026.115054_bb0140","doi-asserted-by":"crossref","DOI":"10.2174\/0118761429254358231120135400","article-title":"Ginsenoside compound K reduces psoriasis-related inflammation by activation of the glucocorticoid receptor in keratinocytes","volume":"17","author":"Wang","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115054_bb0145","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.14053","article-title":"Ginsenoside Rg1 ameliorates psoriasis-like skin lesions by suppressing proliferation and NLRP3 inflammasomes in keratinocytes","volume":"46","author":"Mao","year":"2022","journal-title":"J. Food Biochem."},{"issue":"5 Suppl 93","key":"10.1016\/j.jconrel.2026.115054_bb0150","first-page":"S14","article-title":"The skin in psoriasis: assessment and challenges","volume":"33","author":"Oji","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115054_bb0155","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.4014\/jmb.2301.01028","article-title":"Anti-inflammatory response in TNF\u03b1\/IFN\u03b3-induced HaCaT keratinocytes and probiotic properties of Lacticaseibacillus rhamnosus MG4644, Lacticaseibacillus paracasei MG4693, and Lactococcus lactis MG5474","volume":"33","author":"Lee","year":"2023","journal-title":"J. Microbiol. Biotechnol."},{"issue":"33","key":"10.1016\/j.jconrel.2026.115054_bb0160","article-title":"Antioxidant and prooxidant nanozymes: from cellular redox regulation to next-generation therapeutics","volume":"62","author":"Singh","year":"2023","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2026.115054_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121437","article-title":"Superoxide dismutase-loaded porous polymersomes as highly efficient antioxidant nanoparticles targeting synovium for osteoarthritis therapy","volume":"283","author":"Gui","year":"2022","journal-title":"Biomaterials"},{"issue":"27","key":"10.1016\/j.jconrel.2026.115054_bb0170","doi-asserted-by":"crossref","first-page":"14057","DOI":"10.1021\/acs.langmuir.4c01499","article-title":"Alkanols regulate the fluidity of phospholipid bilayer in accordance to their concentration and polarity","volume":"40","author":"Rai","year":"2024","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2026.115054_bb0175","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jare.2022.09.007","article-title":"Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells","volume":"49","author":"Zhu","year":"2023","journal-title":"J. Adv. Res."},{"issue":"18","key":"10.1016\/j.jconrel.2026.115054_bb0180","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148141","article-title":"Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade","volume":"132","author":"Ghosh","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2026.115054_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115135","article-title":"Old drugs with new applications: tofacitinib-mediated inhibition of M1-like macrophage polarization in acute pancreatitis by the JAK\/STAT and emerging NOD-like receptor pathways","volume":"162","author":"Dai","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"3 Pt B","key":"10.1016\/j.jconrel.2026.115054_bb0190","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jid.2021.06.019","article-title":"Mouse models of psoriasis: a comprehensive review","volume":"142","author":"Gangwar","year":"2022","journal-title":"J. Invest. Dermatol."},{"issue":"6596","key":"10.1016\/j.jconrel.2026.115054_bb0195","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1126\/science.abo0693","article-title":"Microbiota and maintenance of skin barrier function","volume":"376","author":"Harris-Tryon","year":"2022","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115054_bb0200","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1111\/all.16092","article-title":"Skin, gut, and lung barrier: Physiological interface and target of intervention for preventing and treating allergic diseases","volume":"79","author":"Berni Canani","year":"2024","journal-title":"Allergy"},{"issue":"19","key":"10.1016\/j.jconrel.2026.115054_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910841","article-title":"Skin barrier dysregulation in psoriasis","volume":"22","author":"Orsmond","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115054_bb0210","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/art.42960","article-title":"CD4(+)CD8\u03b1(low) T cell clonal expansion dependent on costimulation in patients with rheumatoid arthritis","volume":"76","author":"Beck","year":"2024","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115054_bb0215","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","article-title":"The immunology of psoriasis-current concepts in pathogenesis","volume":"66","author":"Sieminska","year":"2024","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"10275","key":"10.1016\/j.jconrel.2026.115054_bb0220","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115054_bb0225","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/ard-2023-223850","article-title":"Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story","volume":"83","author":"Bonelli","year":"2024","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115054_bb0230","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/ana.26672","article-title":"Shared genetic risk factors for multiple sclerosis\/psoriasis suggest involvement of interleukin-17 and janus kinase-signal transducers and activators of transcription signaling","volume":"94","author":"Patrick","year":"2023","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115054_bb0235","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/rheumatology\/keab740","article-title":"A review of JAK-STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition","volume":"61","author":"Mcinnes","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115054_bb0240","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12964-023-01381-0","article-title":"Triggers for the onset and recurrence of psoriasis: a review and update","volume":"22","author":"Liu","year":"2024","journal-title":"Cell Commun. Signal"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115054_bb0245","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev-immunol-101320-020220","article-title":"The multifaceted role of tissue-resident memory T cells","volume":"42","author":"Christo","year":"2024","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115054_bb0250","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/imm.13843","article-title":"The role and therapeutic strategies for tissue-resident memory T cells, central memory T cells, and effector memory T cells in psoriasis","volume":"173","author":"Deng","year":"2024","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115054_bb0255","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41572-021-00307-9","article-title":"Histiocytic disorders","volume":"7","author":"McClain","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115054_bb0260","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard-2023-225069","article-title":"CD8(+) tissue-resident memory T cells are expanded in primary Sj\u00f6gren\u2019s disease and can be therapeutically targeted by CD103 blockade","volume":"83","author":"Mauro","year":"2024","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115054_bb0265","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a037796","article-title":"Area under immunosurveillance: dedicated roles of memory CD8 T-cell subsets","volume":"12","author":"Parga-Vidal","year":"2020","journal-title":"Cold Spring Harb. Perspect. Biol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926004578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926004578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:52:56Z","timestamp":1793893976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926004578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":53,"alternative-id":["S0168365926004578"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115054","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic remodeling of psoriatic immune niche via ginsenoside CK\/tofacitinib co-loaded dermal targeting transfersomes","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115054"}}